Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...
Post a Comment

Hodgkin’s Lymphoma Treatment Market Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2019 – 2027

Lymphoma is a malignancy that affects the body's lymphocytes, or white blood cells. There are two forms of lymphoma: Hodgkin's and Non- Hodgkin's. Classic Hodgkin's Lymphoma and nodular lymphocyte dominated Hodgkin's Lymphoma are the two types of Hodgkin's Lymphoma. Fever, abrupt weight loss, and swollen lymph nodes are some of the symptoms that indicate the presence of Hodgkin's Lymphoma in the body. Chemotherapy alone or in conjunction with radiotherapy is the most common treatment for Hodgkin's Lymphoma.

 

Global Hodgkin’s Lymphoma Treatment Market Drivers

The global Hodgkin's lymphoma market is predicted to develop as regulatory agencies approve medications for the treatment of Hodgkin's lymphoma. In 2018, Health Canada approved Seattle Genetics, Inc.'s supplementary New Drug Submission, which increases the use of Adcetris (brentuximab vedotin) in combination with AVD (adriamycin, vinblastine, and dacarbazine) chemotherapy in patients with previously untreated Stage IV Hodgkin lymphoma (HL). Adcetris is used in conjunction with doxorubicin, vinblastine, and dacarbazine to treat adult patients with previously untreated Stage III or IV classical Hodgkin lymphoma (cHL).

Furthermore, significant players are always attempting to broaden the scope of their already-approved drug's indications. For example, in March 2017, the US Food and Medication Administration (FDA) approved Merck & Co. Inc.'s drug Keytruda for the treatment of classical Hodgkin's lymphoma. It's approved based on response durability and tumour response rate, and it's supposed to be given to patients intravenously. It was approved for the first time in 2014. The global Hodgkin's lymphoma therapy market is predicted to develop as a result of the frequent approvals of medications by regulatory agencies.

 

Hodgkin's Lymphoma Treatment Market
Hodgkin's Lymphoma Treatment Market

Global Hodgkin’s Lymphoma Treatment Market Regional Analysis

Over the projection period, North America is expected to maintain its dominance in the worldwide Hodgkin's lymphoma market. The expansion of the North American Hodgkin's lymphoma therapy market is predicted to be fueled by frequent research and development activities conducted by the government and other organisations. For example, in December 2016, the Ohio State University Comprehensive Cancer Center and the National Cancer Institute (NCI) started a U.S. FDA clinical trial of Ibrutinib in conjunction with Nivolumab in patients with classical Hodgkin's Lymphoma in the United States to see how effective it is. Ibritunib may inhibit cancer cell growth by inhibiting growth-related enzymes, but Nivolumab may inhibit cancer cell growth by targeting distinct cells. Clinical trials are currently in their second phase. The research will include 17 people and is expected to be completed by 2020.

Comments

Post a Comment

Popular posts from this blog

Future Prospects of Global Laboratory Proficiency Testing Market

Image
Laboratory Proficiency Testing Market  The global Laboratory Proficiency Testing Market is estimated to be valued at US$ 1.29 billion in 2023 and is expected to exhibit a CAGR of 7.3% over the forecast period 2023 - 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: Laboratory proficiency testing involves evaluating the performance of laboratories for a given scope of testing through inter-laboratory comparisons. It helps assess the quality and competence of laboratories by determining reproducibility and accuracy of test results. Proficiency testing products are used by laboratories to determine method validity and accuracy, and improve testing processes. Market Key Trends: One of the major trends in the laboratory proficiency testing market is the growing number of accredited medical laboratories. Accreditation assures compliance with ISO 15189 and ISO/IEC 17025 standards, which require participation in proficiency testing programs. Acc...
Read more

Survival Suits Market Size, Share, Outlook, and Opportunity Analysis, 2023-2030

Image
  Survival Suits Market  Survival suits are protective clothing designed to keep people safe and alive in extreme conditions, such as during a marine emergency or in cold water immersion situations. These suits are also known as immersion suits or survival immersion suits. The survival suits market has seen significant growth in recent years due to increased demand for safety equipment in the marine industry. The survival suits market is driven by several factors, including the need for safety and protection in the marine industry, government regulations mandating the use of survival suits, and advancements in technology. The market is also influenced by the increasing awareness of the importance of safety in marine environments. The marine industry is one of the major users of survival suits. Ships, offshore drilling platforms, and other marine vessels are subject to various risks, including sinking, fire, and explosions. Survival suits are designed to provide protection...
Read more

Global Ophthalmoscopes Market Overview and Impact of Coronavirus (Covid-19) Pandemic

Image
Advanced product development has resulted from technological developments in the realm of disease diagnosis. New ophthalmoscopes are being developed by major manufacturers to meet an unmet need in ocular diagnostic techniques. Over the forecast period, the market is expected to rise due to an increase in product launches by key players. In Japan, for example, Nidek Co. Ltd introduced the Mirante Scanning Laser Ophthalmoscope in 2019. It's a multimodal fundus imaging platform that combines a high-definition scanning laser ophthalmoscope with optical coherence tomography. Furthermore, such new introductions are projected to drive the global ophthalmoscopes market forward.   Ophthalmoscopes Market Global Ophthalmoscopes Market - Impact of Coronavirus (Covid-19) Pandemic Since December 2019, a novel coronavirus has spread throughout China and the rest of the world, resulting in a rapid increase in confirmed cases. The disease has spread to over 100 nations and has been labelle...
Read more